Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition. Find out why AZN stock is a hold.

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...

This was the ADR's second consecutive day of losses.

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell on Wednesday after U.S. President Donald ...

AstraZeneca PLC AZN shares slid 1.44% to £106.62 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.46% to 8,834.03.

Investing.com -- AstraZeneca (NASDAQ: AZN) on Monday night received accelerated approval from the U.S. Food and Drug ...

Tempus AI TEM and Guardant Health GH are two dominant players in the field of AI-powered precision oncology. Tempus, newly ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence ... and cash flow to find stocks that will see sustainable growth over time.